A recent AARP study found that more than half of North Carolina’s family caregivers experienced at least one financial ...
Excerpt from ‘Cancer Gellona’, a public health awareness programme hosted by Walter Nandalike with Dr Suresh Rao, Consultant Radiation Oncologist, MIO Hospital, Mangaluru. Mangaluru, Jan 15: Cancer is ...
A clinical trial held at OU Health showed promising results for proton therapy for certain types of head and neck cancer.
A Phase III clinical trial including patients at the University of Oklahoma found that proton therapy improved survival and ...
LEGENDARY “natural mummy” Ötzi the Iceman was infected with a cancer-causing virus. The ancient human, who live around 5,300 ...
January is the ‘Cervical Cancer Awareness Month’. You must have heard about cervical cancer? It is a cancer that begins on ...
Chennai, Jan. 4 -- Highlights: ...
BioAtla and GATC Health announce $40 million SPV transaction to advance ozuriftamab vedotin into a registrational trial for 2L+ OPSCC: San Diego Saturday, January 3, 2026, 18:00 H ...
A Phase III clinical trial including patients at the University of Oklahoma found that proton therapy improved survival and ...
BioAtla to retain 65% ownership of Oz-V across all solid tumor indications after completion of the SPV transaction. BioAtla will lead Phase 3 trial execution for Oz-V in OPSCC through data readout for ...
Researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy found that ...